highly significantp -value < 0.001
The pharmacokinetic parameters revealed enhancement in oral bioavailability when FLT was delivered as niosomal formulation, confirmed with highly significant AUC 0–∞ with 2 folds increase of FLT-loaded niosomes (741.583 ± 33.557) compared with free FLT suspension (364.536 ± 45.215) that was significant with ( p -value < 0.001).